Real-life experiences with galcanezumab and predictors for treatment response in Turkey

BACKGROUND: The complexity of clinical practice extends far beyond the controlled settings of trials, and there is a need for real-world studies aimed at identifying which patients will respond to anti-CGRP monoclonal antibodies in different countries. This study aimed to investigate the efficacy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yalinay Dikmen, Pınar, Baykan, Betül, Uludüz, Derya, Özge, Aynur, Ilgaz Aydınlar, Elif, Polat, Burcu, Karlı, Necdet, Tepe, Nermin, Çelebisoy, Neşe, Ergin Toktaş, Hayal, Niflioğlu, Buket, Karacı, Rahşan, Mayda Domaç, Füsun, Uludüz, Ezgi, Erdogan Soyukibar, Tuba, Öksüz, Nevra, Ertaş, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666377/
https://www.ncbi.nlm.nih.gov/pubmed/37996793
http://dx.doi.org/10.1186/s12883-023-03467-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666377/
https://www.ncbi.nlm.nih.gov/pubmed/37996793
http://dx.doi.org/10.1186/s12883-023-03467-1

Ejemplares similares